Delaware County Cancels Second Dose Vaccine Appointments Today

David Bjorkgren
By

Severe weather and shipping delays from Moderna have significantly decreased COVID-19 vaccine supplies to providers in Pennsylvania.

As a result, Delaware County government has not received any vaccine for this week and is cancelling all second dose vaccine appointments scheduled for today, Saturday, Feb. 20.

People who are scheduled to receive a second dose on Feb. 20 will be contacted by email or phone to reschedule their appointment when vaccine delivery from the State has been confirmed.

Those scheduled to receive a second dose after Feb. 20 will also be contacted to possibly adjust their appointment if necessary.

Call takers at the Delaware County COVID-19 Call Center can not
reschedule appointments. You will be contacted if your appointment needs to be rescheduled.

The County hopes to provide the second dose of COVID-19 vaccine within the 28- to 42-day window as recommended by the Centers for Disease Control and Prevention (CDC.)

The ability to reschedule is dependent on supply.

Delaware County Council and the County’s Vaccination Team has been in constant contact with state and federal officials to advocate for increased vaccine shipments and for clearer communications regarding
the ongoing status of vaccine production and allocations from the State.

To date, Delaware County Government has requested 14,400 doses from the State and has received just 5,400 doses.

The County has secured the locations, storage and staffing to do large scale community vaccinations and has the ability to vaccinate 10,000 people a week.

The County has two vaccination sites that are up and running in Aston and Yeadon.

Two additional sites in Chester and Springfield had to be placed on hold because of the lack of supply.

There are thousands of staff and volunteers who are trained
and ready once vaccines are available.

The County is also actively seeking out partners and locations to open vaccine clinics using the Pfizer vaccine, which requires a different cold-chain storage than the Moderna vaccine and specific training to administer

Advertisement